Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration
- PMID: 16760229
- DOI: 10.1124/dmd.105.008201
Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration
Abstract
This study was designed to evaluate the use of cerebrospinal fluid (CSF) drug concentration and plasma unbound concentration (C(u,plasma)) to predict brain unbound concentration (C(u,brain)). The concentration-time profiles in CSF, plasma, and brain of seven model compounds were determined after subcutaneous administration in rats. The C(u,brain) was estimated from the product of total brain concentrations and unbound fractions, which were determined using brain tissue slice and brain homogenate methods. For theobromine, theophylline, caffeine, fluoxetine, and propranolol, which represent rapid brain penetration compounds with a simple diffusion mechanism, the ratios of the area under the curve of C(u,brain)/C(CSF) and C(u,brain)/C(u,plasma) were 0.27 to 1.5 and 0.29 to 2.1, respectively, using the brain slice method, and were 0.27 to 2.9 and 0.36 to 3.9, respectively, using the brain homogenate method. A P-glycoprotein substrate, CP-141938 (methoxy-3-[(2-phenyl-piperadinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), had C(u,brain)/C(CSF) and C(u,brain)/C(u,plasma) ratios of 0.57 and 0.066, using the brain slice method, and 1.1 and 0.13, using the brain homogenate method, respectively. The slow brain-penetrating compound, N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl-]sarcosine, had C(u,brain)/C(CSF) and C(u,brain)/C(u,plasma) ratios of 0.94 and 0.12 using the brain slice method and 0.15 and 0.018 using the brain homogenate method, respectively. Therefore, for quick brain penetration with simple diffusion mechanism compounds, C(CSF) and C(u,plasma) represent C(u,brain) equally well; for efflux substrates or slow brain penetration compounds, C(CSF) appears to be equivalent to or more accurate than C(u,plasma) to represent C(u,brain). Thus, we hypothesize that C(CSF) is equivalent to or better than C(u,plasma) to predict C(u,brain). This hypothesis is supported by the literature data.
Similar articles
-
Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.J Pharmacol Exp Ther. 2005 Jun;313(3):1254-62. doi: 10.1124/jpet.104.079319. Epub 2005 Mar 2. J Pharmacol Exp Ther. 2005. PMID: 15743928
-
Use of cassette dosing approach to examine the effects of P-glycoprotein on the brain and cerebrospinal fluid concentrations in wild-type and P-glycoprotein knockout rats.Drug Metab Dispos. 2014 Apr;42(4):482-91. doi: 10.1124/dmd.113.055590. Epub 2014 Jan 7. Drug Metab Dispos. 2014. PMID: 24398459
-
An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations.Drug Metab Dispos. 2012 Nov;40(11):2162-73. doi: 10.1124/dmd.112.046391. Epub 2012 Aug 16. Drug Metab Dispos. 2012. PMID: 22899853
-
A Practical Perspective on the Evaluation of Small Molecule CNS Penetration in Drug Discovery.Drug Metab Lett. 2019;13(2):78-94. doi: 10.2174/1872312813666190311125652. Drug Metab Lett. 2019. PMID: 30854983 Review.
-
Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.Adv Drug Deliv Rev. 2004 Oct 14;56(12):1825-57. doi: 10.1016/j.addr.2004.07.011. Adv Drug Deliv Rev. 2004. PMID: 15381336 Review.
Cited by
-
Opioid and neuroHIV Comorbidity - Current and Future Perspectives.J Neuroimmune Pharmacol. 2020 Dec;15(4):584-627. doi: 10.1007/s11481-020-09941-8. Epub 2020 Sep 2. J Neuroimmune Pharmacol. 2020. PMID: 32876803 Free PMC article. Review.
-
Choroid Plexus and Drug Removal Mechanisms.AAPS J. 2021 May 3;23(3):61. doi: 10.1208/s12248-021-00587-9. AAPS J. 2021. PMID: 33942198 Review.
-
Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain.Biochem Pharmacol. 2007 Jan 1;73(1):147-54. doi: 10.1016/j.bcp.2006.09.008. Epub 2006 Sep 14. Biochem Pharmacol. 2007. PMID: 17046718 Free PMC article.
-
Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insights.Mult Scler J Exp Transl Clin. 2021 Nov 3;7(4):20552173211049168. doi: 10.1177/20552173211049168. eCollection 2021 Oct. Mult Scler J Exp Transl Clin. 2021. PMID: 34777855 Free PMC article.
-
Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics.Animal Model Exp Med. 2018 Dec 4;1(4):314-321. doi: 10.1002/ame2.12046. eCollection 2018 Dec. Animal Model Exp Med. 2018. PMID: 30891581 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous